Toyoshi Tatekawa

1.9k total citations
22 papers, 1.5k citations indexed

About

Toyoshi Tatekawa is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Toyoshi Tatekawa has authored 22 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Hematology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Toyoshi Tatekawa's work include Renal and related cancers (9 papers), Acute Lymphoblastic Leukemia research (5 papers) and Acute Myeloid Leukemia Research (3 papers). Toyoshi Tatekawa is often cited by papers focused on Renal and related cancers (9 papers), Acute Lymphoblastic Leukemia research (5 papers) and Acute Myeloid Leukemia Research (3 papers). Toyoshi Tatekawa collaborates with scholars based in Japan and India. Toyoshi Tatekawa's co-authors include Yusuke Oji, Hiroya Tamaki, Hiroyasu Ogawa, Haruo Sugiyama, Yoshitaka Oka, Kazushi Inoue, Toshihiro Soma, Akihiro Tsuboi, Tetsu Akiyama and Manabu Kawakami and has published in prestigious journals such as Blood, Transplantation and Leukemia.

In The Last Decade

Toyoshi Tatekawa

22 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toyoshi Tatekawa Japan 14 1.1k 464 427 346 229 22 1.5k
Sumiyuki Nishida Japan 23 1.0k 0.9× 270 0.6× 352 0.8× 571 1.7× 554 2.4× 83 1.7k
SE Sallan United States 11 322 0.3× 775 1.7× 609 1.4× 251 0.7× 317 1.4× 14 1.4k
Olga A. Elisseeva Japan 15 682 0.6× 163 0.4× 147 0.3× 359 1.0× 364 1.6× 17 926
Tatsuya Fujioka Japan 19 448 0.4× 237 0.5× 750 1.8× 277 0.8× 451 2.0× 60 1.3k
Michele Malagola Italy 23 488 0.4× 336 0.7× 1.0k 2.5× 248 0.7× 137 0.6× 107 1.5k
ER van Wering Netherlands 17 347 0.3× 1.2k 2.6× 1.0k 2.4× 264 0.8× 276 1.2× 17 1.7k
Michael Neat United Kingdom 18 493 0.4× 188 0.4× 557 1.3× 259 0.7× 95 0.4× 38 1.1k
Fernando Ramos Spain 21 524 0.5× 445 1.0× 1.2k 2.7× 201 0.6× 118 0.5× 68 1.5k
M Malec Sweden 5 722 0.6× 888 1.9× 1.6k 3.8× 173 0.5× 134 0.6× 7 2.1k
AD Ho Germany 18 244 0.2× 152 0.3× 709 1.7× 399 1.2× 246 1.1× 32 1.2k

Countries citing papers authored by Toyoshi Tatekawa

Since Specialization
Citations

This map shows the geographic impact of Toyoshi Tatekawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toyoshi Tatekawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toyoshi Tatekawa more than expected).

Fields of papers citing papers by Toyoshi Tatekawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toyoshi Tatekawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toyoshi Tatekawa. The network helps show where Toyoshi Tatekawa may publish in the future.

Co-authorship network of co-authors of Toyoshi Tatekawa

This figure shows the co-authorship network connecting the top 25 collaborators of Toyoshi Tatekawa. A scholar is included among the top collaborators of Toyoshi Tatekawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toyoshi Tatekawa. Toyoshi Tatekawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tatekawa, Toyoshi, Hiroyasu Ogawa, M Kawakami, et al.. (2006). A novel direct competitive repopulation assay for human hematopoietic stem cells using NOD/SCID mice. Cytotherapy. 8(4). 390–398. 4 indexed citations
2.
Kawakami, Manabu, Jun Nakata, Nobuyuki Ohguro, et al.. (2005). A case of immune recovery vitritis induced by donor leukocyte infusion for the treatment of cytomegalovirus retinitis. European Journal Of Haematology. 75(4). 352–354. 6 indexed citations
3.
Ishii, Taeko, Toyoshi Tatekawa, Masaru Ishii, et al.. (2003). A case of multicentric Castleman's disease demonstrating severe eosinophilia and enhanced production of interleukin‐5. European Journal Of Haematology. 70(2). 115–118. 9 indexed citations
4.
5.
Ogawa, Hiroyasu, Toshihiro Soma, Naoki Hosen, et al.. (2002). Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation. Transplantation. 74(2). 236–243. 13 indexed citations
6.
Murakami, Akiko, et al.. (2001). Hemophagocytic syndrome in a patient with systemic lupus erythematosus.. Nihon Naika Gakkai Zasshi. 90(4). 696–698. 4 indexed citations
7.
Kakazu, Naoki, Masafumi Taniwaki, Shigeo Horiike, et al.. (1999). Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome. Genes Chromosomes and Cancer. 26(4). 336–345. 82 indexed citations
8.
9.
Oji, Yusuke, Hiroya Tamaki, Yoshitaka Oka, et al.. (1999). Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth. Japanese Journal of Cancer Research. 90(2). 194–204. 172 indexed citations
10.
Tamaki, Hiroya, Hiroyasu Ogawa, Kazuma Ohyashiki, et al.. (1999). The Wilms’ tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes. Leukemia. 13(3). 393–399. 144 indexed citations
11.
Kakazu, Naoki, Masafumi Taniwaki, Shigeo Horiike, et al.. (1999). Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome. Genes Chromosomes and Cancer. 26(4). 336–345. 1 indexed citations
12.
Soma, Toshihiro, Toyoshi Tatekawa, Yusuke Oji, et al.. (1998). High Incidence of Chemotherapy-Induced Acral Erythema in Female Patients with non-Hodgkin's Lymphoma Treated with the Vacop-B Regimen. Leukemia & lymphoma. 29(1-2). 171–177. 8 indexed citations
13.
Inoue, Kazushi, Hiroya Tamaki, Hiroyasu Ogawa, et al.. (1998). Wilms' Tumor Gene (WT1) Competes With Differentiation-Inducing Signal in Hematopoietic Progenitor Cells. Blood. 91(8). 2969–2976. 136 indexed citations
14.
Inoue, Kazushi, Hiroyasu Ogawa, Yoshiaki Sonoda, et al.. (1997). Aberrant Overexpression of the Wilms Tumor Gene (WT1) in Human Leukemia. Blood. 89(4). 1405–1412. 298 indexed citations
15.
Tamaki, Hiroya, Hiroyasu Ogawa, Kazushi Inoue, et al.. (1996). Increased expression of the Wilms tumor gene (WT1) at relapse in acute leukemia [letter]. Blood. 88(11). 4396–4398. 39 indexed citations
16.
Yamagami, T, Haruo Sugiyama, Kazushi Inoue, et al.. (1996). Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood. 87(7). 2878–2884. 214 indexed citations
17.
Kanno, Hiroyuki, et al.. (1996). Interleukin-6-mediated growth enhancement of cell lines derived from pyothorax-associated lymphoma.. PubMed. 75(2). 167–73. 35 indexed citations
18.
Inoue, Kouji, Hiroyuki Ogawa, Toru Yamagami, et al.. (1996). Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels. Blood. 88(6). 2267–2278. 152 indexed citations
19.
Yoshida, Hisao, Toyoshi Tatekawa, Naoomi Tominaga, et al.. (1993). [Two cases of acute myelogenous leukemia with Bacillus cereus bacteremia resulting in fatal intracranial hemorrhage].. PubMed. 34(12). 1568–72. 11 indexed citations
20.
Kouhara, Haruhiko, Toyoshi Tatekawa, Masafumi Koga, et al.. (1992). Intracranial and Intraspinal Dissemination of an ACTH-Secreting Pituitary Tumor. Endocrinologia Japonica. 39(2). 177–184. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sumiyuki Nishida Breakdown of academic impact, for papers by SE Sallan Breakdown of academic impact, for papers by Olga A. Elisseeva Breakdown of academic impact, for papers by Tatsuya Fujioka Breakdown of academic impact, for papers by Michele Malagola Breakdown of academic impact, for papers by ER van Wering Breakdown of academic impact, for papers by Michael Neat Breakdown of academic impact, for papers by Fernando Ramos Breakdown of academic impact, for papers by M Malec Breakdown of academic impact, for papers by AD Ho
Rankless by CCL
2026